182 related articles for article (PubMed ID: 21741841)
1. Muscle atrophy in muscle-specific tyrosine kinase (MuSK)-related myasthenia gravis.
Moon SY; Lee SS; Hong YH
J Clin Neurosci; 2011 Sep; 18(9):1274-5. PubMed ID: 21741841
[TBL] [Abstract][Full Text] [Related]
2. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
[TBL] [Abstract][Full Text] [Related]
3. MRI evidence of early muscle atrophy in MuSK positive myasthenia gravis.
Zouvelou V; Rentzos M; Toulas P; Evdokimidis I
J Neuroimaging; 2011 Jul; 21(3):303-5. PubMed ID: 20002967
[TBL] [Abstract][Full Text] [Related]
4. Experience with patients with anti-MUSK antibody positive myasthenia gravis.
Sundar U; Shaunbhag P; Lakkas Y; Shrivastava M; Shah A; Vaidya M; Asole D
J Assoc Physicians India; 2010 Oct; 58():640-2. PubMed ID: 21510119
[TBL] [Abstract][Full Text] [Related]
5. Myopathy, muscle atrophy and tongue lipid composition in MuSK myasthenia gravis.
Nikolić AV; Bačić GG; Daković MŽ; Lavrnić SĐ; Rakočević Stojanović VM; Basta IZ; Lavrnić DV
Acta Neurol Belg; 2015 Sep; 115(3):361-5. PubMed ID: 25253293
[TBL] [Abstract][Full Text] [Related]
6. AchR-positive myasthenia gravis with MRI evidence of early muscle atrophy.
Zouvelou V; Rentzos M; Toulas P; Evdokimidis I
J Clin Neurosci; 2012 Jun; 19(6):918-9. PubMed ID: 22341149
[TBL] [Abstract][Full Text] [Related]
7. Antibodies against Wnt receptor of muscle-specific tyrosine kinase in myasthenia gravis.
Takamori M; Nakamura T; Motomura M
J Neuroimmunol; 2013 Jan; 254(1-2):183-6. PubMed ID: 22999188
[TBL] [Abstract][Full Text] [Related]
8. Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
Farrugia ME; Kennett RP; Hilton-Jones D; Newsom-Davis J; Vincent A
Clin Neurophysiol; 2007 Feb; 118(2):269-77. PubMed ID: 17157556
[TBL] [Abstract][Full Text] [Related]
9. Sarcoidosis in a case of MuSK-positive myasthenia gravis.
Spengos K; Vassilopoulou S; Christou Y; Manta P
Neuromuscul Disord; 2008 Nov; 18(11):890-1. PubMed ID: 18815037
[TBL] [Abstract][Full Text] [Related]
10. Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis.
Guptill JT; Sanders DB
Curr Opin Neurol; 2010 Oct; 23(5):530-5. PubMed ID: 20613516
[TBL] [Abstract][Full Text] [Related]
11. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome.
Díaz-Manera J; Rojas-García R; Gallardo E; Juárez C; Martínez-Domeño A; Martínez-Ramírez S; Dalmau J; Blesa R; Illa I
Nat Clin Pract Neurol; 2007 Jul; 3(7):405-10. PubMed ID: 17611489
[TBL] [Abstract][Full Text] [Related]
13. Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis.
Farrugia ME; Kennett RP; Newsom-Davis J; Hilton-Jones D; Vincent A
Muscle Nerve; 2006 Apr; 33(4):568-70. PubMed ID: 16382443
[TBL] [Abstract][Full Text] [Related]
14. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
Caress JB; Hunt CH; Batish SD
Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
[TBL] [Abstract][Full Text] [Related]
15. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
[TBL] [Abstract][Full Text] [Related]
16. MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo.
Benveniste O; Jacobson L; Farrugia ME; Clover L; Vincent A
J Neuroimmunol; 2005 Dec; 170(1-2):41-8. PubMed ID: 16213598
[TBL] [Abstract][Full Text] [Related]
17. Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive myasthenia gravis.
Wolfe GI; Oh SJ
Ann N Y Acad Sci; 2008; 1132():71-5. PubMed ID: 18567855
[TBL] [Abstract][Full Text] [Related]
18. Ocular myasthenia: a rare presentation with MuSK antibody and bilateral extraocular muscle atrophy.
Chan JW; Orrison WW
Br J Ophthalmol; 2007 Jun; 91(6):842-3. PubMed ID: 17510484
[No Abstract] [Full Text] [Related]
19. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
[TBL] [Abstract][Full Text] [Related]
20. Are MuSK antibodies the primary cause of myasthenic symptoms?
Selcen D; Fukuda T; Shen XM; Engel AG
Neurology; 2004 Jun; 62(11):1945-50. PubMed ID: 15184594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]